Protagonist Therapeutics (PTGX) Short Interest Ratio & Short Volume → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free PTGX Stock Alerts $29.98 -0.43 (-1.41%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Protagonist Therapeutics Short Interest DataCurrent Short Interest3,470,000 sharesPrevious Short Interest3,730,000 sharesChange Vs. Previous Month-6.97%Dollar Volume Sold Short$109.20 millionShort Interest Ratio6.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares58,650,000 sharesPercentage of Shares Shorted5.92%Today's Trading Volume434,104 sharesAverage Trading Volume653,331 sharesToday's Volume Vs. Average66% Short Selling Protagonist Therapeutics ? Sign up to receive the latest short interest report for Protagonist Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPTGX Short Interest Over TimePTGX Days to Cover Over TimePTGX Percentage of Float Shorted Over Time Ad American AlternativeYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW Protagonist Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20243,470,000 shares $109.20 million -7.0%N/A6.3 $31.47 4/30/20243,730,000 shares $93.66 million +6.0%N/A6.6 $25.11 4/15/20243,520,000 shares $93.56 million +2.3%N/A5.2 $26.58 3/31/20243,440,000 shares $99.52 million +0.6%N/A4.6 $28.93 3/15/20243,420,000 shares $99.11 million +16.3%N/A4.7 $28.98 2/29/20242,940,000 shares $89.32 million +5.8%N/A3.6 $30.38 Get the Latest News and Ratings for PTGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20242,780,000 shares $78.48 million +6.5%N/A3.5 $28.23 1/31/20242,610,000 shares $65.28 million +2.4%N/A3.2 $25.01 1/15/20242,550,000 shares $66.05 million +8.5%N/A3.5 $25.90 12/31/20232,350,000 shares $53.89 million -41.0%N/A3.3 $22.93 12/15/20233,980,000 shares $83.86 million +9.3%N/A5.6 $21.07 11/30/20233,640,000 shares $66.28 million -0.3%N/A5.4 $18.21 11/15/20233,650,000 shares $59.46 million -7.4%N/A5.7 $16.29 10/31/20233,940,000 shares $57.29 million +15.5%N/A6 $14.54 10/15/20233,410,000 shares $52.65 million +8.3%N/A5.3 $15.44 9/30/20233,150,000 shares $52.54 million +12.5%N/A4.5 $16.68 9/15/20232,800,000 shares $50.12 million +1.8%N/A3 $17.90 8/31/20232,750,000 shares $54.51 million -9.2%N/A2.8 $19.82 8/15/20233,030,000 shares $56.84 million +2.0%N/A2.8 $18.76 7/31/20232,970,000 shares $57.62 million -10.5%N/A2.7 $19.40 7/15/20233,320,000 shares $70.55 million +4.4%N/A2.8 $21.25 6/30/20233,180,000 shares $87.83 million +18.2%N/A2.7 $27.62 6/15/20232,690,000 shares $77.15 million -12.1%N/A2.5 $28.68 5/31/20233,060,000 shares $79.77 million -15.0%N/A2.5 $26.07 5/15/20233,600,000 shares $93.49 million -3.2%N/A2.2 $25.97 4/30/20233,720,000 shares $84.07 million -14.7%N/A2.2 $22.60 4/15/20234,360,000 shares $81.71 million +0.5%N/A2.5 $18.74 3/31/20234,340,000 shares $99.82 million -16.1%N/A2.6 $23.00 3/15/20235,170,000 shares $124.34 million +88.7%N/A3.2 $24.05 2/28/20232,740,000 shares $44.44 million +5.4%6.3%1.9 $16.22 2/15/20232,600,000 shares $42.43 million +2.0%6.0%2.5 $16.32 1/31/20232,550,000 shares $33.89 million +25.6%5.9%2.7 $13.29 1/15/20232,030,000 shares $24.71 million +14.0%4.7%2.4 $12.17 12/30/20221,780,000 shares $19.42 million -4.3%4.1%2.3 $10.91 12/15/20221,860,000 shares $17.73 million +6.9%4.3%2.4 $9.53 11/30/20221,740,000 shares $13.76 million -4.4%4.0%2.2 $7.91 11/15/20221,820,000 shares $14.63 million -7.6%4.2%2.4 $8.04 10/31/20221,970,000 shares $15.96 million -11.7%4.5%2.5 $8.10 10/15/20222,230,000 shares $17.82 million -8.2%5.1%2.6 $7.99 9/30/20222,430,000 shares $20.48 million -13.5%5.6%2.7 $8.43Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution 9/15/20222,810,000 shares $23.24 million +9.3%6.5%2.8 $8.27 8/31/20222,570,000 shares $22.41 million -11.4%5.9%2.4 $8.72 8/15/20222,900,000 shares $32.86 million -31.6%6.7%2.7 $11.33 7/31/20224,240,000 shares $42.19 million -13.1%N/A3.5 $9.95 7/15/20224,880,000 shares $46.16 million +2.3%N/A3.5 $9.46 6/30/20224,770,000 shares $37.73 million +18.4%N/A3.4 $7.91 6/15/20224,030,000 shares $30.14 million +18.9%N/A3 $7.48 5/31/20223,390,000 shares $29.70 million +1.5%N/A2.9 $8.76 5/15/20223,340,000 shares $29.43 million +1.5%N/A2.9 $8.81 4/30/20223,290,000 shares $29.91 million +20.5%N/A3.1 $9.09 4/15/20222,730,000 shares $54.46 million -16.3%N/A3.3 $19.95 3/31/20223,260,000 shares $77.20 million -17.5%N/A4.6 $23.68 3/15/20223,950,000 shares $101.99 million -0.8%N/A5.7 $25.82 2/28/20223,980,000 shares $96.63 million -19.1%N/A5.6 $24.28 2/15/20224,920,000 shares $141.35 million +25.5%N/A7.3 $28.73 1/31/20223,920,000 shares $114.82 million +9.5%N/A6.4 $29.29 1/15/20223,580,000 shares $128.74 million +10.2%N/A5.9 $35.96 12/31/20213,250,000 shares $111.15 million +2.2%N/A2.4 $34.20 12/15/20213,180,000 shares $97.12 million +2.6%N/A2.2 $30.54 11/30/20213,100,000 shares $104.22 million -17.6%7.3%1.6 $33.62 11/15/20213,760,000 shares $134.38 million -15.1%8.8%1.9 $35.74 10/29/20214,430,000 shares $138.04 million +18.5%10.5%2.3 $31.16 10/15/20213,740,000 shares $115.83 million +2.8%8.9%2 $30.97 9/30/20213,640,000 shares $64.50 million +27.3%8.7%2.1 $17.72 9/15/20212,860,000 shares $132.90 million -6.5%6.8%3 $46.47 8/31/20213,060,000 shares $148.41 million -4.4%7.3%7.3 $48.50 8/13/20213,200,000 shares $152.61 million +5.6%7.6%7.3 $47.69 7/30/20213,030,000 shares $149.77 million -11.1%7.3%6.9 $49.43 7/15/20213,410,000 shares $150.93 million -1.7%8.3%8.1 $44.26 6/30/20213,470,000 shares $155.73 million -1.4%8.5%8.5 $44.88 6/15/20213,520,000 shares $134.29 million -3.8%8.6%9.3 $38.15 5/28/20213,660,000 shares $128.50 million -6.2%9.7%11.6 $35.11 5/14/20213,900,000 shares $113.10 million +26.2%N/A12.2 $29.00 4/30/20213,090,000 shares $92.67 million +1.6%N/A9.2 $29.99 4/15/20213,040,000 shares $79.01 million +0.3%N/A9.1 $25.99 3/31/20213,030,000 shares $76.69 million +5.6%N/A8.5 $25.31 3/15/20212,870,000 shares $88.97 million +3.6%N/A6.4 $31.00 2/26/20212,770,000 shares $66.45 million -0.4%N/A5.6 $23.99 2/12/20212,780,000 shares $69.75 million +1.5%N/A5.9 $25.09 1/29/20212,740,000 shares $58.25 million -13.6%N/A5.7 $21.26 1/15/20213,170,000 shares $72.43 million -7.9%N/A6.6 $22.85 12/31/20203,440,000 shares $68.77 million +28.4%N/A7.6 $19.99 12/15/20202,680,000 shares $56.07 million +6.8%N/A6.6 $20.92 11/30/20202,510,000 shares $59.86 million -1.6%N/A6.9 $23.85 11/15/20202,550,000 shares $56.64 million No ChangeN/A7.2 $22.21 10/30/20202,550,000 shares $47.15 million -6.9%N/A7.2 $18.49 10/15/20202,740,000 shares $57.46 million -16.5%N/A7.9 $20.97 9/30/20203,280,000 shares $64.12 million +45.8%N/A9.5 $19.55 9/15/20202,250,000 shares $48.74 million +16.0%N/A6.3 $21.66 8/31/20201,940,000 shares $43.46 million +12.1%N/A5.4 $22.40Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution 8/14/20201,730,000 shares $27.14 million +8.8%N/A4.2 $15.69 7/31/20201,590,000 shares $25.01 million +15.2%N/A2.8 $15.73 7/15/20201,380,000 shares $21.51 million +4.6%N/A1.3 $15.59 6/30/20201,320,000 shares $23.31 million -9.6%N/A1.2 $17.66 6/15/20201,460,000 shares $23.51 million +29.2%N/A1.4 $16.10 5/29/20201,130,000 shares $18.69 million -11.7%N/A1.2 $16.54 5/15/20201,280,000 shares $20.74 million +14.3%N/A1.4 $16.20 4/30/20201,120,000 shares $7.56 million -13.9%5.4%1.5 $6.75 4/15/20201,300,000 shares $8.87 million +4.0%6.3%8.6 $6.82 3/31/20201,250,000 shares $8.14 million -8.2%6.1%7.5 $6.51 3/13/20201,362,300 shares $9.47 million +14.5%7.0%9.5 $6.95 2/28/20201,190,000 shares $7.14 million -11.9%6.1%5.7 $6.00 2/14/20201,350,000 shares $10.30 million +3.9%6.9%2.1 $7.63 1/31/20201,300,000 shares $10.82 million +4.8%6.9%2 $8.32 1/15/20201,240,000 shares $10.39 million -20.5%6.5%1.9 $8.38 12/31/20191,560,000 shares $11.73 million +39.3%8.2%2.4 $7.52 PTGX Short Interest - Frequently Asked Questions What is Protagonist Therapeutics' current short interest? Short interest is the volume of Protagonist Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 3,470,000 shares of PTGX short. Learn More on Protagonist Therapeutics' current short interest. What is a good short interest ratio for Protagonist Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PTGX shares currently have a short interest ratio of 6.0. Learn More on Protagonist Therapeutics's short interest ratio. Which institutional investors are shorting Protagonist Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Protagonist Therapeutics: PEAK6 Investments LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Protagonist Therapeutics' short interest increasing or decreasing? Protagonist Therapeutics saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 3,470,000 shares, a drop of 7.0% from the previous total of 3,730,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Protagonist Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Protagonist Therapeutics: Galapagos NV (2.43%), Keros Therapeutics, Inc. (6.74%), Evotec SE (0.04%), Ardelyx, Inc. (14.20%), Agios Pharmaceuticals, Inc. (10.97%), Catalyst Pharmaceuticals, Inc. (7.86%), Syndax Pharmaceuticals, Inc. (11.80%), NewAmsterdam Pharma (0.37%), Zai Lab Limited (3.31%), Rocket Pharmaceuticals, Inc. (11.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Protagonist Therapeutics stock? Short selling PTGX is an investing strategy that aims to generate trading profit from Protagonist Therapeutics as its price is falling. PTGX shares are trading down $0.43 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Protagonist Therapeutics? A short squeeze for Protagonist Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PTGX, which in turn drives the price of the stock up even further. How often is Protagonist Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTGX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Galapagos Short Interest Keros Therapeutics Short Interest Evotec Short Interest Ardelyx Short Interest Agios Pharmaceuticals Short Interest Catalyst Pharmaceuticals Short Interest Syndax Pharmaceuticals Short Interest NewAmsterdam Pharma Short Interest Zai Lab Short Interest Rocket Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PTGX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeWARNING about the death of the U.S. dollar…Colonial MetalsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagonist Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.